A re-analysis of a clinical trial of GlaxoSmithKline's antidepressant Seroxat suggests the drug is ineffective and unsafe in younger patients, contradicting its earlier conclusions. The new study ...
In October, the MHRA reviewed data from the earliest trials of Seroxat. The information was supplied by GlaxoSmithKline in the late Eighties, and it was the MHRA's responsibility to analyse the ...
In the ongoing litigation over Apotex's generic version of GlaxoSmithKline's (GSK) antidepressant paroxetine hydrochloride (Paxil), the US Federal Circuit Appeals Court has reversed the previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback